Medicine and Dentistry
Neoplasm
100%
Pediatrics
73%
Ewing Sarcoma
55%
Cyclophosphamide
45%
Bone Marrow Transplantation
42%
T Cell
39%
Hematologic Malignancy
36%
Colorectal Cancer
35%
Sarcoma
35%
Programmed Death-Ligand 1
30%
Soft Tissue Sarcoma
29%
Graft Versus Host Reaction
29%
Disease
27%
Malignant Neoplasm
26%
DNA Mismatch Repair
24%
Pediatric Cancer
22%
Hematopoietic Stem Cell Transplantation
22%
Cumulative Incidence
19%
Overall Survival
18%
Metastatic Carcinoma
17%
Biological Marker
16%
Disease Course
15%
Immunosuppressive Treatment
15%
Engraftment
15%
Metastatic Colorectal Cancer
14%
Immunotherapy
14%
Rhabdomyosarcoma
14%
Progression Free Survival
14%
Cancer
14%
Cytotoxic T-Cell
14%
Prophylaxis
13%
Immunosuppressive Drug
13%
Recurrent Disease
13%
Cancer Immunotherapy
13%
Transcriptomics
12%
Macrophage
12%
Immunocompetent Cell
12%
Hazard Ratio
11%
Colorectal Tumor
11%
Tertiary Lymphoid Structure
11%
Gene Fusion
11%
Jumping
11%
Irinotecan
11%
Giant Cell Tumor of Tendon Sheath
11%
T Lymphocyte Receptor
11%
Germinoma
11%
Immunoglobulin
11%
Malignant Peripheral Nerve Sheath Tumor
11%
Activin
11%
Activin Receptor
11%
Keyphrases
Pediatric
62%
Post-transplantation Cyclophosphamide (PTCy)
57%
Graft-versus-host Disease (GvHD)
45%
Haploidentical Transplantation
42%
Tumor
41%
Colorectal Cancer
41%
Hematological Malignancies
37%
Young Adult Patients
35%
Ewing Sarcoma
28%
Pediatric Cancer
22%
Hematopoietic Stem Cell Transplantation
22%
Microsatellite Instable
22%
Programmed Death-ligand 1 (PD-L1)
21%
High Risk
21%
Myeloablative
18%
Immune Checkpoint
18%
Older Adults
18%
Soft Tissue Sarcoma
18%
Immune Microenvironment
18%
Tumor Microenvironment
17%
Progression-free Survival
17%
Haploidentical BMT
17%
Mismatch Repair
17%
Immunosuppression
15%
Metastatic Colorectal Cancer (mCRC)
14%
Transplant-related Mortality
14%
Graft-versus-host Disease Prophylaxis
14%
Clinical Course
14%
Single Institution
14%
Engraftment
14%
Solid Tumors
14%
Overall Survival
14%
Chemotherapy
13%
Cumulative Incidence
12%
T-cell Replete
12%
T Cells
12%
Tumor-infiltrating Lymphocytes
11%
Donor T Cell
11%
Human Leukocyte Antigen
11%
Suppression Mechanism
11%
Bone Marrow Transplantation
11%
Colorectal Tumor
11%
Initial Diagnosis
11%
Checkpoint Blockade
11%
Cyclin-dependent Kinase 4 (CDK4)
11%
Neuroglial
11%
Testicular Germ Cell Tumor
11%
Mouse Model
11%
Fibrolamellar Carcinoma
11%
Personalized Detection
11%
Immunology and Microbiology
Cyclophosphamide
57%
Bone Marrow Transplantation
54%
T Cell
51%
Pseudomonas aeruginosa
45%
Graft-Versus-Host Disease
37%
Hematopoietic Stem Cell Transplantation
34%
Colon
27%
Mouse
26%
Conditioning
25%
Tumor-Infiltrating Lymphocytes
23%
Conjugate Vaccine
22%
Flagellin
22%
Immunotherapy
20%
Transplant Procedure
19%
Monospecific Antibody
19%
Vaccine Efficacy
18%
Immunosuppressive Drug
17%
Engraftment
17%
Programmed Death-Ligand 1
15%
Immunosuppression
15%
Transcriptomics
15%
Mismatch Repair
14%
Mouse Model
14%
T-Helper Cell
14%
Intravenous Immunoglobulin
13%
Cytotoxic T Cell
13%
Tumor-Associated Macrophage
13%
Cancer Immunotherapy
13%
Immunocompetent Cell
11%
Human Leukocyte Antigen
11%
Expression Analysis
11%
T Cell Receptor
11%
Chimeric Antigen Receptor T-Cell Therapy
11%
Alloimmunity
11%
Activin
11%
Human Monoclonal Antibody
11%
Microsatellite Instability
11%
Flagellum
11%
Nivolumab
11%
Soft Tissue
11%
in Situ Hybridization
11%
Th17 Cell
11%
Tertiary Lymphoid Structure
11%
CD8
10%
Progression Free Survival
10%
Platelet
8%
Chronic Graft Versus Host Disease
8%
Transcription Factors
8%
Mycophenolic Acid
8%
Acute Graft Versus Host Disease
8%
